Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma neurofilament light, glial fibrillary acidic protein and lysosphingolipid biomarkers for pharmacodynamics and disease monitoring of GM2 and GM1 gangliosidoses patients
Richard W.D. Welford, Hervé Farine, Michel A. Steiner, et al.
Molecular Genetics and Metabolism Reports (2022) Vol. 30, pp. 100843-100843
Open Access | Times Cited: 18

Showing 18 citing articles:

The 2022 Lady Estelle Wolfson lectureship on neurofilaments
Axel Petzold
Journal of Neurochemistry (2022) Vol. 163, Iss. 3, pp. 179-219
Open Access | Times Cited: 31
Biomarkers for gene therapy clinical trials of lysosomal storage disorders
Alessandro Rossi, Sabrina Malvagia, Giancarlo la Marca, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2930-2938
Closed Access | Times Cited: 5
Emerging biomarkers in Gaucher disease
Danielle M Luettel, Márcia R. Terluk, Jaehyeok Roh, et al.
Advances in clinical chemistry (2025), pp. 1-56
Closed Access
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 Gangliosidosis
Sydney Stern, Karryn Crisamore, Ruo‐Jing Li, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Sinbaglustat ameliorates disease pathology in a murine model of GM1 gangliosidosis without affecting CNS ganglioside levels
Rouven Wannemacher, Lorna Jubran-Rudolf, Isabel Zdora, et al.
Neurobiology of Disease (2025), pp. 106917-106917
Open Access
Biomarkers for predicting disease course in Sanfilippo syndrome: An urgent unmet need in childhood‐onset dementia
Leanne K. Winner, Mary‐Louise Rogers, Marten F. Snel, et al.
Journal of Neurochemistry (2023) Vol. 166, Iss. 3, pp. 481-496
Open Access | Times Cited: 8
Plasma neurofilament light chain is increased in Niemann-Pick Type C but glial fibrillary acidic protein remains normal
Dhamidhu Eratne, Courtney Lewis, Wendy Kelso, et al.
Acta Neuropsychiatrica (2024), pp. 1-6
Closed Access | Times Cited: 2
Sphingolipids and their role in health and disease in the central nervous system
Andrés Felipe Leal, Diego A. Súarez, Olga Yaneth Echeverri-Peña, et al.
Advances in Biological Regulation (2022) Vol. 85, pp. 100900-100900
Open Access | Times Cited: 8
Plasma GM2 ganglioside potential biomarker for diagnosis, prognosis and disease monitoring of GM2-Gangliosidosis
Amélie Blondel, Ichraf Kraoua, Chloé Marcelino, et al.
Molecular Genetics and Metabolism (2022) Vol. 138, Iss. 2, pp. 106983-106983
Open Access | Times Cited: 6
Familial Alzheimer’s disease associated with heterozygousNPC1mutation
Diego Lopergolo, Silvia Bianchi, Gian Nicola Gallus, et al.
Journal of Medical Genetics (2023) Vol. 61, Iss. 4, pp. 332-339
Closed Access | Times Cited: 3
Decreasing ganglioside synthesis delays motor and cognitive symptom onset inSpg11knockout mice
Manon Fortier, Margaux Cauhapé, Suzie Buono, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout mice
Manon Fortier, Margaux Cauhapé, Suzie Buono, et al.
Neurobiology of Disease (2024) Vol. 199, pp. 106564-106564
Open Access
A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis
Jin Yong Kim, Seul Kee Byeon, Devin Oglesbee, et al.
Analytical and Bioanalytical Chemistry (2024) Vol. 416, Iss. 26, pp. 5689-5699
Open Access
Myeloid-derived β-hexosaminidase is essential for neuronal health and lysosome function: implications for Sandhoff disease
Kate I. Tsourmas, Claire A. Butler, Nellie Kwang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Endocannabinoid receptor 2 is a potential biomarker and therapeutic target for the lysosomal storage disorders
Calogera M. Simonaro, Makiko Yasuda, Edward H. Schuchman
Journal of Inherited Metabolic Disease (2024)
Open Access
UPLC-MS/MS High-Risk Screening for Sphingolipidoses Using Dried Urine Spots
Tristan Martineau, Bruno Maranda, Christiane Auray‐Blais
Biomolecules (2024) Vol. 14, Iss. 12, pp. 1612-1612
Open Access
Lysosphingolipid Quantitation in Plasma and Dried‐Blood Spots Using Targeted High‐Resolution Mass Spectrometry
Franklin Ducatez, Wladimir Mauhin, Javier I. Ottaviani, et al.
Journal of Clinical Laboratory Analysis (2024) Vol. 39, Iss. 1
Open Access
Plasma neurofilament light chain is elevated in Niemann-Pick Type C but glial fibrillary acidic protein is not
Dhamidhu Eratne, Courtney Lewis, Wendy Kelso, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top